Osteopenia Withdrawn Phase 2 Trials for Teriparatide (DB06285)

Also known as: Osteopaenia / Bone loss

IndicationStatusPhase
DBCOND0015922 (Osteopenia)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00624481Study to Evaluate Effect of Intranasal Teriparatide on Bone Mineral Density in Postmenopausal Women With Low BMDTreatment